Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 570

1.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr; Mirtazapine vs. Paroxetine Study Group.

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50.

PMID:
12213688
[PubMed - indexed for MEDLINE]
2.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.

Int Clin Psychopharmacol. 1999 Nov;14(6):329-37.

PMID:
10565799
[PubMed - indexed for MEDLINE]
4.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.

Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.

Int Clin Psychopharmacol. 2003 May;18(3):133-41.

PMID:
12702891
[PubMed - indexed for MEDLINE]
6.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
7.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
[PubMed - indexed for MEDLINE]
8.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team.

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
[PubMed - indexed for MEDLINE]
9.

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

Wheatley DP, van Moffaert M, Timmerman L, Kremer CM.

J Clin Psychiatry. 1998 Jun;59(6):306-12.

PMID:
9671343
[PubMed - indexed for MEDLINE]
10.
11.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

PMID:
10446737
[PubMed - indexed for MEDLINE]
12.

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.

J Clin Psychiatry. 2003 Apr;64(4):413-20.

PMID:
12716243
[PubMed - indexed for MEDLINE]
13.

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.

Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H; Mirtazapine in the Nursing Home Study Group.

Curr Med Res Opin. 2003;19(8):737-46.

PMID:
14687445
[PubMed - indexed for MEDLINE]
14.

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.

J Clin Psychopharmacol. 2006 Feb;26(1):75-8.

PMID:
16415711
[PubMed - indexed for MEDLINE]
15.

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

Hong CJ, Hu WH, Chen CC, Hsiao CC, Tsai SJ, Ruwe FJ.

J Clin Psychiatry. 2003 Aug;64(8):921-6.

PMID:
12927007
[PubMed - indexed for MEDLINE]
16.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.

J Clin Psychiatry. 2001 Jun;62(6):413-20.

PMID:
11465517
[PubMed - indexed for MEDLINE]
18.

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.

Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015. Epub 2009 Apr 2.

PMID:
19345072
[PubMed - indexed for MEDLINE]
19.

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.

Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y.

Int Clin Psychopharmacol. 2000 Jan;15(1):43-8.

PMID:
10836286
[PubMed - indexed for MEDLINE]
20.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk